about
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.The Prognostic Impact of Unplanned Excisions in a Cohort of 728 Soft Tissue Sarcoma Patients: A Multicentre StudyRed cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortalityPrevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.Resistance to EGFR targeting therapies in lung cancer.Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants.Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VPodoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.Long-term cardiovascular complications in stage I seminoma patients.NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause.Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS).Triglycerides and Open Angle Glaucoma - A Meta-analysis with meta-regression.Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma.Elevated serum creatinine and low albumin are associated with poor outcomes in patients with liposarcoma.MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.Serum integrin-linked kinase (sILK) concentration and survival in non-small cell lung cancer: a pilot study.Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.Inflammatory Biomarkers in Diffuse Large B-Cell Lymphoma: Time for Extending the Established Prognosis Scores?Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.Association of thrombin generation potential with platelet PAR-1 regulation and P-selectin expression in patients on dual antiplatelet therapy.Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality.Statins are Associated with Low Risk of Venous Thromboembolism in Patients with Cancer: A Prospective and Observational Cohort StudySingle-stage revision for the infected total knee replacement: results from a single centreSerum creatinine and albumin predict sarcoma-specific survival in patients with myofibroblastic and fibroblastic sarcomasOC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?Symptoms, signs, suspicion and setting: a PESI score for cancer-associated pulmonary embolism?
P50
Q33590396-3DACC7CD-11D3-49E4-9C83-2310608CC881Q33627814-1E26D75F-F5C7-4CDF-99CB-353CA91A241DQ34408343-5E983871-7940-4ACA-86DC-CA5AC7DDB711Q36239524-6960A52A-A00E-4F22-A117-825CE70447D2Q36248404-D4FE9EAC-D415-4CF8-8C94-D56E1D9BE9A0Q36558396-C343EA19-53B0-48EA-8227-95176C7C9496Q36749420-7CCBEC1B-6202-4744-BD3E-5FAEAD62B6E8Q37960925-9E877282-86DF-4AE8-9321-60E32890D72BQ38554324-ECABC625-BDBD-45B5-8D9C-F078D0C8F954Q38607054-519BB313-73FD-49D6-9644-A340BC2BBD70Q39028469-B7BAE0AB-8271-488C-B4C5-A68FD4EE24C1Q40065469-B190D846-4A1B-4655-A5EA-0F78CB3F86C5Q40496418-DB180549-5604-49F5-B7EA-C1C4F21346B0Q40942451-05FCAE67-F81C-42C5-9F22-4BD2914298FCQ41157732-F1DAE4C0-179D-417E-AA55-BA93F3CFE37DQ41354254-3DA4B295-0F49-4C93-834D-17121B4267B7Q41456560-77FB4EF3-821C-4E95-B12A-457044438C24Q41496658-15F09938-F795-47AE-98C7-EA7870DBD99FQ41534599-B515D43C-2FDE-4861-B99B-8B9BFD0C2BD9Q41660637-37FCC2E0-4A0D-4EB5-A698-8668EADF1024Q41812070-28FE8429-8FCA-4AB6-A2A5-C4FB1A52D2E2Q45013092-994CCC88-DB36-4887-8C3E-F74A5189DA26Q48123193-3D1C235A-D861-4A2C-9C7F-F334512C103FQ50142799-93546910-AF65-486D-BE07-1DC913ACAEF4Q50958158-15AEDC56-1B14-498A-96D3-E09F7B2B6A36Q52762113-16F2B3E8-8E95-45D0-889B-544853DCFCFBQ53072423-79250B6E-7C5E-4C57-8F3B-35FE78EA10F7Q53221654-A98F127F-C751-45B8-940E-5F1A212FAD03Q53656553-388CC046-DE0D-4E12-B224-03BEB3EEAE70Q64135005-192142E7-6A4F-47FA-BC5A-0466A8E87014Q88009776-0D67A287-6E82-4EC3-8161-BFEBDEA0A593Q88020839-5FE726CE-A1DF-4726-A67D-2683471ACEB6Q89401085-072D9005-8366-4DB5-B1FD-0D014D16F177Q89445075-AE7334A6-9A03-4346-97CC-66289129EC53
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Florian Posch
@ast
Florian Posch
@en
Florian Posch
@es
Florian Posch
@nl
Florian Posch
@sl
type
label
Florian Posch
@ast
Florian Posch
@en
Florian Posch
@es
Florian Posch
@nl
Florian Posch
@sl
prefLabel
Florian Posch
@ast
Florian Posch
@en
Florian Posch
@es
Florian Posch
@nl
Florian Posch
@sl
P106
P21
P31
P496
0000-0002-0448-6314